Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
GLP-1 does not see much medical use without modifications, while Ozempic is proven through clinical trials and prescribed
So where does that leave us
1921 Recently, a double-blind, placebo-controlled randomized clinical trial of phase I study of (in)GSH in PD ( n =30) demonstrated (in)GSH was safe and tolerable, and both active study arms demonstrated an improvement over placebo in total Unified PD Rating Scale scores, specifically in activities of daily living and motor Unified PD Rating Scale subscores
Eli Lilly's Zepbound/Mounjaro (tirzepatide) is the big challenger to Wegovy in the injectable category at the moment, and a similar two-horse race is being set up in the oral space as Lilly prepares to file its oral GLP-1 agonist orforglipron for approval before the end of the year
US$ 28.69
US$ 29.36
US$ 23.60
US$ 20.46
